Cyclosporine Amicellar delivery system for dry eyes

References

• LallemandFFelt-BaeyensOBesseghirKBehar-CohenFGurnyRCyclosporine A delivery to the eye: a pharmaceutical challengeEur J Pharm Biopharm200356330731814602172
   PubMed Web of Science ®Google Scholar
• KashaniSMearzaAAUses and safety profile of ciclosporin in ophthalmologyExpert Opin Drug Saf200871798918171316
   PubMed Web of Science ®Google Scholar
• KarnPRChoWParkHJParkJSHwangSJCharacterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham methodInt J Nanomedicine2013836537723378759
   PubMed Web of Science ®Google Scholar
• Rodriguez-AllerMKaufmannBGuillarmeDIn vivo characterisation of a novel water-soluble cyclosporine A prodrug for the treatment of dry eye diseaseEur J Pharm Biopharm201280354455222155591
   PubMed Web of Science ®Google Scholar
• NobleSMarkhamACyclosporin: a review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral)Drugs19955059249418586033
   PubMed Web of Science ®Google Scholar
• MondonKZeisser-LabouèbeMGurnyRMöllerMNovel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability studyEur J Pharm Biopharm2011771566520888909
   PubMed Web of Science ®Google Scholar
• Di TommasoCBourgesJLValamaneshFNovel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studiesEur J Pharm Biopharm201281225726422445900
   PubMed Web of Science ®Google Scholar
• StrickleyRGSolubilizing excipients in oral and injectable formulationsPharm Res200421220123015032302
   PubMed Web of Science ®Google Scholar
• JavadiMAFeiziSDry eye syndromeJ Ophthalmic Vis Res20116319219822454735
   PubMedGoogle Scholar
• PflugfelderSCAntiinflammatory therapy for dry eyeAm J Ophthalmol2004137233734214962426
   PubMed Web of Science ®Google Scholar
• SchaumbergDASullivanDABuringJEDanaMRPrevalence of dry eye syndrome among US womenAm J Ophthalmol2003136231832612888056
   PubMed Web of Science ®Google Scholar
• KarnPRKimHDKangHSunBKJinSEHwangSJSupercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsionInt J Nanomedicine201493791380025143728
   PubMed Web of Science ®Google Scholar
• GuptaCChauhanAOphthalmic delivery of cyclosporine A by punctal plugsJ Control Release20111501707621074586
   PubMed Web of Science ®Google Scholar
• AliabadiHMBrocksDRLavasanifarAPolymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistributionBiomaterials200526357251725916005061
   PubMed Web of Science ®Google Scholar
• KuwanoMIbukiHMorikawaNOtaAKawashimaYCyclosporine A formulation affects its ocular distribution in rabbitsPharm Res200219110811111837694
   PubMed Web of Science ®Google Scholar
• LuschmannCTessmarJSchoeberlSStraussOLuschmannKGoepferichASelf-assembling colloidal system for the ocular administration of cyclosporine ACornea2014331778124162754
   PubMed Web of Science ®Google Scholar
• CholkarKGilgerBCMitraAKTopical, aqueous, clear cyclosporine formulation design for anterior and posterior ocular deliveryTransl Vis Sci Technol201543125964868
   PubMed Web of Science ®Google Scholar
• JiaoJPolyoxyethylated nonionic surfactants and their applications in topical ocular drug deliveryAdv Drug Deliv Rev200860151663167318845195
   PubMed Web of Science ®Google Scholar
• RoggebandRYorkMPericoiMBraunWEye irritation responses in rabbit and man after single applications of equal volumes of undiluted model liquid detergent productsFood Chem Toxicol200038872773410908820
   PubMed Web of Science ®Google Scholar
• AmmarHOSalamaHAGhorabMMahmoudAANanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochlorideAAPS PharmSciTech200910380881919536653
   PubMed Web of Science ®Google Scholar
• van der BijlPvan EykADMeyerDEffects of three penetration enhancers on transcorneal permeation of cyclosporineCornea200120550550811413407
   PubMed Web of Science ®Google Scholar
• BurgalassiSPanichiLChetoniPSaettoneMFBoldriniEDevelopment of a simple dry eye model in the albino rabbit and evaluation of some tear substitutesOphthalmic Res199931322923510224507
   PubMed Web of Science ®Google Scholar
• GinJWongVGinventorsVisionex, assigneeSchirmer tear testUnited States patent US5006310199149
   Google Scholar
• KunertKSTisdaleASGipsonIKGoblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporineArch Ophthalmol2002120333033711879137
   PubMedGoogle Scholar
• DursunDWangMMonroyDA mouse model of keratoconjunctivitis siccaInvest Ophthalmol Vis Sci200243363263811867577
   PubMed Web of Science ®Google Scholar
• StevensonDTauberJReisBLEfficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trialOphthalmology2000107596797410811092
   PubMed Web of Science ®Google Scholar
• van der BijlPEngelbrechtAHVan EykADMeyerDComparative permeability of human and rabbit corneas to cyclosporin and tritiated waterJ Ocul Pharmacol Ther200218541942712419093
   PubMedGoogle Scholar
• DasSMondalSGhoshSPhysicochemical studies on the micellization of cationic, anionic, and nonionic surfactants in water-polar organic solvent mixturesJ Chem Eng Data201358925862595
   Google Scholar
• van TellingenOHuizingMTPandayVRSchellensJHNooijenWJBeijnenJHCremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patientsBr J Cancer199981233033510496361
   PubMed Web of Science ®Google Scholar
• TorchilinVPMicellar nanocarriers: pharmaceutical perspectivesPharm Res200724111617109211
   PubMed Web of Science ®Google Scholar
• BonannoJAPolseKAMeasurement of in vivo human corneal stromal pH: open and closed eyesInvest Ophthalmol Vis Sci19872835225303557865
   PubMed Web of Science ®Google Scholar
• ColesWHJarosPADynamics of ocular surface pHBr J Ophthalmol19846885495526743624
   PubMed Web of Science ®Google Scholar
• MisselPJLangJCRodeheaverDPDesign and evaluation of ophthalmic pharmaceutical productsFlorenceATSiepmannJModern Pharmaceutics5th edBoca Raton (FL)CRC Press2009101189
   Google Scholar
• SuzukiMMassingaleMLYeFTear osmolarity as a biomarker for dry eye disease severityInvest Ophthalmol Vis Sci20105194557456120393114
   PubMedGoogle Scholar
• BeauchesnePRChungNSWasanKMCyclosporine A: a review of current oral and intravenous delivery systemsDrug Dev Ind Pharm200733321122017454054
   PubMed Web of Science ®Google Scholar
• el TayarNMarkAEVallatPBrunneRMTestaBvan GunsterenWFSolvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulationsJ Med Chem19933624375737648254605
   PubMed Web of Science ®Google Scholar
• MithaniSDBakatselouVTenHoorCNDressmanJBEstimation of the increase in solubility of drugs as a function of bile salt concentrationPharm Res19961311631678668668
   PubMedGoogle Scholar
• AcheampongAAShackletonMTang-LiuDDDingSSternMEDeckerRDistribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogsCurr Eye Res19991829110310223652
   PubMed Web of Science ®Google Scholar
• ShatosMARiosJDHorikawaYIsolation and characterization of cultured human conjunctival goblet cellsInvest Ophthalmol Vis Sci20034462477248612766046
   PubMedGoogle Scholar
• ChaoCCButalaSMHerpAStudies on the isolation and composition of human ocular mucinExp Eye Res19884721851963409990
   PubMedGoogle Scholar
• HollyFJLempMAWettability and wetting of corneal epitheliumExp Eye Res19711122392505121745
   PubMed Web of Science ®Google Scholar
• WatanabeHSignificance of mucin on the ocular surfaceCornea2002212 Suppl 1S17S2211995804
   PubMedGoogle Scholar
• XiongCChenDLiuJA rabbit dry eye model induced by topical medication of a preservative benzalkonium chlorideInvest Ophthalmol Vis Sci20084951850185618436819
   PubMed Web of Science ®Google Scholar
• BarabinoSShenLChenLRashidSRolandoMDanaMRThe controlled-environment chamber: a new mouse model of dry eyeInvest Ophthalmol Vis Sci20054682766277116043849
   PubMedGoogle Scholar
• PflugfelderSCDe PaivaCSVillarrealALSternMEEffects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-β2 productionCornea2008271646918245969
   PubMed Web of Science ®Google Scholar
• KinoshitaSKiorpesTCFriendJThoftRAGoblet cell density in ocular surface disease: a better indicator than tear mucinArch Ophthalmol19831018128412876882259
   PubMedGoogle Scholar